US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 13.450
  • -0.050-0.37%
Trading Dec 4 09:37 ET
1.23BMarket Cap-4926P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
6.11%69.42M
7.21%73.71M
8.33%67.38M
16.00%259.66M
-7.73%63.28M
11.87%65.43M
26.83%68.76M
46.12%62.19M
34.64%223.84M
56.46%68.58M
Selling and administrative expenses
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
40.70%58.77M
68.30%19.05M
-General and administrative expense
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
40.70%58.77M
68.30%19.05M
Research and development costs
-9.67%42.32M
-9.80%46.35M
-2.47%45.23M
12.55%186.34M
-16.57%41.74M
7.98%46.84M
24.25%51.38M
50.58%46.37M
31.95%165.57M
51.55%50.04M
Other operating expenses
----
----
----
----
----
----
----
----
50.00%-500K
----
Operating profit
-6.11%-69.42M
-7.21%-73.71M
-8.33%-67.38M
-16.00%-259.66M
7.73%-63.28M
-11.87%-65.43M
-26.83%-68.76M
-46.12%-62.19M
-34.64%-223.84M
-56.46%-68.58M
Net non-operating interest income expense
-23.37%2.71M
33.05%4.07M
37.89%5.32M
610.30%14.06M
94.67%3.62M
382.24%3.53M
1,691.67%3.06M
1,023.21%3.86M
170.19%1.98M
549.03%1.86M
Non-operating interest income
-20.58%3.18M
28.75%4.54M
33.86%5.79M
309.85%15.94M
228.43%4.09M
195.57%4M
426.76%3.52M
594.54%4.33M
26.76%3.89M
46.47%1.25M
Non-operating interest expense
0.43%471K
0.64%471K
0.64%471K
-1.78%1.88M
176.55%470K
-24.48%469K
-45.64%468K
-55.04%468K
-67.58%1.91M
-148.58%-614K
Other net income (expense)
Income before tax
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
Income tax
Net income
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
Net income continuous Operations
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
Minority interest income
Net income attributable to the parent company
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
Basic earnings per share
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
-22.10%-3.26
-28.99%-0.89
Diluted earnings per share
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
-22.10%-3.26
-28.99%-0.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 6.11%69.42M7.21%73.71M8.33%67.38M16.00%259.66M-7.73%63.28M11.87%65.43M26.83%68.76M46.12%62.19M34.64%223.84M56.46%68.58M
Selling and administrative expenses 45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M40.70%58.77M68.30%19.05M
-General and administrative expense 45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M40.70%58.77M68.30%19.05M
Research and development costs -9.67%42.32M-9.80%46.35M-2.47%45.23M12.55%186.34M-16.57%41.74M7.98%46.84M24.25%51.38M50.58%46.37M31.95%165.57M51.55%50.04M
Other operating expenses --------------------------------50.00%-500K----
Operating profit -6.11%-69.42M-7.21%-73.71M-8.33%-67.38M-16.00%-259.66M7.73%-63.28M-11.87%-65.43M-26.83%-68.76M-46.12%-62.19M-34.64%-223.84M-56.46%-68.58M
Net non-operating interest income expense -23.37%2.71M33.05%4.07M37.89%5.32M610.30%14.06M94.67%3.62M382.24%3.53M1,691.67%3.06M1,023.21%3.86M170.19%1.98M549.03%1.86M
Non-operating interest income -20.58%3.18M28.75%4.54M33.86%5.79M309.85%15.94M228.43%4.09M195.57%4M426.76%3.52M594.54%4.33M26.76%3.89M46.47%1.25M
Non-operating interest expense 0.43%471K0.64%471K0.64%471K-1.78%1.88M176.55%470K-24.48%469K-45.64%468K-55.04%468K-67.58%1.91M-148.58%-614K
Other net income (expense)
Income before tax -7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M
Income tax
Net income -7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M
Net income continuous Operations -7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M
Minority interest income
Net income attributable to the parent company -7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M
Basic earnings per share 5.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73-22.10%-3.26-28.99%-0.89
Diluted earnings per share 5.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73-22.10%-3.26-28.99%-0.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data